| Industry Range | | Price / Earnings | 23.45 | |
| Book Value | 6.82 | |
| Earnings Per Share | $0.92 | |
| Price To Sales Ratio | 4.90 | |
| Price To Book Ratio | 2.97 | |
| Price To Tangible Book Ratio | 3.06 | |
| Price/Cash Flow Ratio | 17.87 | |
| Price/Free Cash Flow Ratio | 71.48 | |
| Industry Range | | Market Capitalization | 6.7B | |
| Float (MRQ) | 97.76% | |
| Shares Outstanding (MRQ) | 319.6M | |
| Short Interest as a % of Float (MRQ) | 3.82% | |
| Shares Held By Institutions (MRQ) | 269.5M | |
| Industry Range | | Sales | $1.5B | |
| Gross Margin | 96.52% | |
| Net Profit Margin | 19.60% | |
| EBIT Margin | 24.63% | |
| EBITDA Margin | 25.88% | |
| Operating Margins | 24.63% | |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
| Industry Range | | Current Ratio (MRQ) | 5.43 | |
| Quick Ratio (MRQ) | 5.35 | |
| Total Debt/Equity Ratio (MRQ) | 2.21 | |
| Debt/Common Equity Ratio (MRQ) | 2.21 | |
| Industry Range | | Return on Equity | 13.77% | |
| Return on Assets | 17.20% | |
| Asset Turnover | 0.88 | |
| Receivables Turnover | 7.29 | |
| Inventory Turnover | 1.94 | |
| Industry Range | | EPS Growth Annual | 360.00% | |
| Dividend Yield 5 Year Average | 0.00% | |
| Current Dividend Yield | 0.00% | |
| Current Payout Ratio | 0.00 | |
*EXEL does not pay a dividend. The average dividend yield for companies in the Biotechnology industry is 1.50%